10.02.2011 • News
Novartis
10.02.2011 • News
Russia Set for More Inward Pharma Investment
01.02.2011 • News
Toshiba Faces $100 Million Gender Bias Lawsuit
31.01.2011 • News
M&A Is Back As CEOs Start To Put Cash To Work
26.01.2011 • Topics • Technology
The Pharmaceutical Industry On The Move
21.12.2010 • News
Genzyme Argues Campath Value In Sanofi Fight
02.12.2010 • News
Novartis to Slash 1,400 U.S. Jobs
22.11.2010 • News
Novartis: No Plans to Slash Jobs
22.11.2010 • News
Biosimilar Antibodies: EMA Adopts Guideline
18.11.2010 • News
Novartis Won’t Go All-Cash on Alcon Deal
17.11.2010 • News
Novartis Efficiency Drive To Boost Profitability
17.11.2010 • News
Biosimilar Antibodies: EU Likely to Be Cautious
23.08.2010 • News
Novartis Banking on Swiss Law for Alcon Deal
10.08.2010 • News
Novartis/Alcon Deal Cleared by EU Regulators
02.08.2010 • News
White Knight Could Be Elusive For Genzyme
15.07.2010 • News
Novartis in $175 Million Gender Bias Settlement
12.07.2010 • News
Novartis Still Seeking To Buy Out Alcon
01.07.2010 • News
Cutting Drug Prices Hampers New Development
Camelot Management Consultants AG
Styron Europe GmbH
F. Hoffmann-La Roche Ltd
Isomorphic Labs
Arthur D. Little
Getec Group
Novartis International AG
ISPE D/A/CH e.V.
Merck KGaA
Chemical Market Reporter
Microinnova Engineering GmbH
Oracle Germany
EvaluatePharma
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
GlobalData
SchüllerConsulting
Novartis Vaccines and Diagnostics GmbH & Co.KG
Frost & Sullivan
Novartis Pharma GmbH
Thomson Reuters
CONTINUUS Pharmaceuticals, Inc.
KPMG
ACIB Austrian Centre of Industrial Biotechnology